oneotherfool

oneotherfool
Send Message
View as an RSS Feed
  • The Truth About WidePoint: The Irrationally Priced Micro Cap With Big Potential  [View article]
    They took their position in the 4th quarter, so it was 50-100% higher than here, but yes, it's still not very much...But from Widepoint's perspective, they still count in the top 5 due to the lack of institutional ownership in general.... None the less it's still a good sign. But I agree with you about management and their communication. They've just looking the other way, when it comes to share price.
    Feb 13, 2016. 05:02 PM | Likes Like |Link to Comment
  • The Truth About WidePoint: The Irrationally Priced Micro Cap With Big Potential  [View article]
    On a happier note, B. Riley took a position in widepoint in Q4. They're now in the top 5 institutional holders (close to 500k shares. ) They're one of the two analysts that actually cover this stock and are sync with the company.

    So, there isn't anyone out there that's more familiar/ knowledgeable with what's going on with Widepoint. I'll take that as a positive sign.

    Someone stepped in today mid day to flush out the seller...Have a good weekend everyone!
    Feb 12, 2016. 07:18 PM | Likes Like |Link to Comment
  • The Truth About WidePoint: The Irrationally Priced Micro Cap With Big Potential  [View article]
    So what the hell is going on here? Ask is stacked up with a lot of supply, hitting the bid and taking it down one penny at a time, then you see the giant ask move down...

    Again, what's going on here? It's trading at $0.47 as I'm typing. What is Nokomis doing? What is management doing? Has anyone tried to get in touch with either?
    Feb 12, 2016. 10:48 AM | Likes Like |Link to Comment
  • LeapFrog bought out by Vtech  [View news story]
    So is $LF playing games to get bidders interested? Conspiracy...

    How could they even entertain such offer? Quarter must have been horrific..and they knew they would be shut for good going forward...if that's the case, heck, why even go through with this quarter? Why waste the cash? Just sell the company in December, you'd have it in cash. Something is fishy here...something is not being said. This must be one of the most incompetent management team I have ever seen.
    Feb 6, 2016. 01:41 AM | 3 Likes Like |Link to Comment
  • Sunshine Heart - A Speculative Biotech Play For Substantial Short-Term Gains  [View article]
    Dude, I believe you are misinterpreting the post.

    This is not saying that 75% of pulse are denied, they are putting in perspective the percentage of applications that get value 1 vs value 4 vs rejected. C pulse is one example out if theses 710 procedures, that got a 4. Cpulse falls into the the 5%....(Obviously, there had not been 710 c pulse procedures.)

    That is not bad news, if im reading this correctly. While not great news ( it would have been if they got a 1) but at least it wasn't rejected like the 75%...
    Feb 3, 2016. 10:23 PM | 1 Like Like |Link to Comment
  • Sunshine Heart - A Speculative Biotech Play For Substantial Short-Term Gains  [View article]
    Yes, really, in the case he provided...of course it is at the discretion of management, by the definition of a poison pill. Geez, don't be a wise....
    Jan 30, 2016. 12:39 AM | Likes Like |Link to Comment
  • The Truth About WidePoint: The Irrationally Priced Micro Cap With Big Potential  [View article]
    Maybe I'll listen to the last webcast this weekend, and see if I can come up with a question or two. Appreciate the effort on your end to put a call together.
    Jan 29, 2016. 06:31 PM | Likes Like |Link to Comment
  • Sunshine Heart - A Speculative Biotech Play For Substantial Short-Term Gains  [View article]
    NOT an option. That's why there's a "poison pill" in place. This has been brought up over and over...If you've missed it, you can even search for the word "poison" on this page, and you'll find the answers.
    Jan 29, 2016. 02:58 PM | Likes Like |Link to Comment
  • The Truth About WidePoint: The Irrationally Priced Micro Cap With Big Potential  [View article]
    VVC,

    Just wondering, have you ever tried to get intouch with IR or management? I'm asking you because you spent the time to research and write the article.... I haven't personally. But maybe we should.

    I wonder if we ask specific questions and send them over (as oppose to sending typical retail rants).

    Thoughts?
    Jan 29, 2016. 02:56 PM | Likes Like |Link to Comment
  • The Truth About WidePoint: The Irrationally Priced Micro Cap With Big Potential  [View article]
    I have to blame management for not setting expectations right. Delays are fine, as long as they're put in context. It's the lack of clarity that is getting to the equity, not the actual delays.

    When you throw around $70-$80M as a possible revenue number for 2016 (assuming we don't sign contracts) spooks everyone...yea, no sh*t we better get at least as much revenue for 2016 when compared to 2015.

    Also, the lack of quantifying COD potential revenue and being very vague about it doesn't help. While it's great to hear about "we may sign with X and we may sign with Y"...this is not cutting it anymore; It's show me the money time...If management haven't picked up on that yet, it's really concerning...It's not good to have the equity hang around in penny land at <0.60 this long...this is absurd. Not doing anything about it is even more absurd.

    They have 2 analysts barely covering the stock...It's almost as though they consider them as "good enough" for investors out there...This BS is gotta stop!

    Note that I haven't made any comments to criticize the actual work they're doing, or the fundamentals of the company. I still believe we're in good shape for decent upside, and that's why I'm holding....but you can't kick the can anymore with the lack of clarity...
    Jan 29, 2016. 01:39 PM | Likes Like |Link to Comment
  • Sunshine Heart - A Speculative Biotech Play For Substantial Short-Term Gains  [View article]
    All of this is reasonable and I fully agree with everything you wrote in your reply. I just disagreed before on a buyout/merger price.

    "a moderate reduction of the cash burn to gain a few more months may indeed make sense,"

    Absolutely...that would be crucial for any negotiation, if indeed what we're speculating is true...Let's hope, if they have a plan, it gets announced soon, we're testing that $1 level way too often....
    Jan 17, 2016. 06:45 PM | Likes Like |Link to Comment
  • Sunshine Heart - A Speculative Biotech Play For Substantial Short-Term Gains  [View article]
    I'm a long, and would love for your speculation to be true. But saying "Based on my analysis, a merger can result in an acquisition share price in the range of $177 - $710, " is none-sense. No way in hell this will happen in the next 2-3 years, let alone "coming days or weeks".

    I'd be amazed, shocked, and positively surprised, if we get $17. We won't. Realistically, it will be in the high single digit, if anything. Yes...i know about the potential market and what could sales look like at one point in the future, but SSH does NOT have that kind of leverage to get offers like the one you mention, not even offers in the double digits share price...they just renegotiated a loan that forces them to keep 6 months of cash on hand at all time...

    The ONLY leverage they have is one that you and Robert speak of, possibility of more than one buyer, this is where you go back and forth between them and sell for the highest bidder. That's it...Keep in mind, any buyer knows that if they drag their feet a little bit, SSH will get into a tougher and tougher spot, where they need to take the deal whatever it is...they're not stupid. Let's be real.

    With all that said, your article is great and informative. Thank you.
    Jan 17, 2016. 01:43 AM | Likes Like |Link to Comment
  • Why Big Biotech Will Outperform The Market In 2016  [View article]
    Well, it's sure not looking that way so far. The $IBB has dropped twice as much as the S&P since Dec 31st. $IBB is down over 10% in 5 trading days. S&P is down 5%. Nasdaq is somewhere in between.

    I sure do hope you're right about 2016 in general. Yes hope is not a strategy, but I'm outta cash :)
    Jan 7, 2016. 04:35 PM | Likes Like |Link to Comment
  • MannKind Plunges On Termination Of Sanofi Agreement - What Investors Need To Consider  [View article]
    Spencer, thanks for the nice summary. I just want to clarify something to readers about the Nasdaq delisting, to follow up on what you said.

    If the stock does trade at <$1 for 30 consecutive days, the "delisting process" starts with a notice of delisting. The company then will automatically have 180 days to remain compliance. It's also typical that the company will ask for another 180 days extension (total one year), from the date the notice is issued, to regain compliance (however they achieve it, whether by actually trading above a $1 again for 10 consecutive days, or through a RS).
    Jan 6, 2016. 01:19 AM | 13 Likes Like |Link to Comment
  • Sunshine Heart: Ironically, A Cash Crisis May Result In Better Outcomes For Shareholders  [View article]
    I stand corrected. Now that you mentioned those buys, I remembered "tweeting" about them here "http://seekingalpha.co..."

    I guess it has been a LONG 4 months with the share price getting cut in half since those buys.

    Thanks for pointing it out.
    Dec 24, 2015. 12:37 AM | 1 Like Like |Link to Comment
COMMENTS STATS
332 Comments
549 Likes